問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
周文堅
下載
2024-11-20 - 2034-12-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2022-12-01 - 2031-12-31
Chronic Lymphocytic Leukemia、Small Lymphocytic Lymphoma
1026FludarabineCyclophosphamideMK-1026
Participate Sites3Sites
Recruiting3Sites
2022-02-04 - 2025-06-13
2021-10-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2023-01-02 - 2029-06-01
Adult Acute Myeloid Leukemia
mocravimod
Participate Sites4Sites
Recruiting4Sites
2023-06-01 - 2028-03-31
Participate Sites5Sites
Not yet recruiting4Sites
Recruiting1Sites
2023-01-23 - 2027-10-13
Participate Sites2Sites
Recruiting2Sites
2022-11-01 - 2037-11-01
Not yet recruiting1Sites
2022-04-01 - 2027-12-31
2021-09-02 - 2026-09-09
全部
